Wednesday, October 19, 2016

Primsol


Primsol is a brand name of trimethoprim, approved by the FDA in the following formulation(s):


PRIMSOL (trimethoprim hydrochloride - solution; oral)



  • Manufacturer: FSC

    Approval date: January 24, 2000

    Strength(s): EQ 50MG BASE/5ML [RLD]

Has a generic version of Primsol been approved?


No. There is currently no therapeutically equivalent version of Primsol available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Primsol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
    Patent 5,763,449
    Issued: June 9, 1998
    Inventor(s): Anaebonam; Aloysius O. & Clemente; Emmett & Fawzy; Abdel A.
    Assignee(s): Ascent Pediatrics, Inc.
    A liquid pharmaceutical composition is contemplated that comprises a pharmaceutically effective amount of a bitter tasting drug dissolved or dispersed in an aqueous medium that is free of ethanol. That aqueous medium consists essentially of water, about 5 to about 30 weight percent polyvinylpyrrolidone, about 45 to about 55 weight percent of a C.sub.3 -C.sub.6 polyol, about 0.01 to about 0.5 weight percent ammonium glycyrrhizinate and one or more flavorants. The liquid composition is transparent and has a pleasant taste.
    Patent expiration dates:

    • August 7, 2016




  • Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
    Patent 5,962,461
    Issued: October 5, 1999
    Inventor(s): Anaebonam; Aloysius O. & Clemente; Emmett & Fawzy; Abdel A.
    Assignee(s): Ascent Pediatrics, Inc.
    A liquid pharmaceutical composition is contemplated that comprises a pharmaceutically effective amount of a bitter tasting drug dissolved or dispersed in an aqueous medium that is free of ethanol. That aqueous medium consists essentially of water, about 5 to about 30 weight percent polyvinylpyrrolidone, about 35 to about 55 weight percent of a C.sub.3 -C.sub.6 polyol, about 0.01 to about 0.5 weight percent ammonium glycyrrhizinate and one or more flavorants. The liquid composition is transparent and has a pleasant taste. The bitter tasting drugs claimed herein are vitamin and mineral preparations, trimethoprim, and guaifenesin.
    Patent expiration dates:

    • August 7, 2016



See also...

  • Primsol Solution Consumer Information (Wolters Kluwer)
  • Primsol Consumer Information (Cerner Multum)
  • Primsol Advanced Consumer Information (Micromedex)
  • Trimethoprim Consumer Information (Wolters Kluwer)
  • Trimethoprim Solution Consumer Information (Wolters Kluwer)
  • Trimethoprim Consumer Information (Cerner Multum)
  • Trimethoprim Advanced Consumer Information (Micromedex)
  • Trimethoprim AHFS DI Monographs (ASHP)

Tuesday, October 18, 2016

Sitosterin Prostata-Kapseln




Sitosterin Prostata-Kapseln may be available in the countries listed below.


Ingredient matches for Sitosterin Prostata-Kapseln



Sitosterol, β-

Sitosterol, β- is reported as an ingredient of Sitosterin Prostata-Kapseln in the following countries:


  • Germany

International Drug Name Search


Skanoorin




Skanoorin may be available in the countries listed below.


Ingredient matches for Skanoorin



Sulindac

Sulindac is reported as an ingredient of Skanoorin in the following countries:


  • Japan

International Drug Name Search


Wick-Inhalierstift




Wick-Inhalierstift may be available in the countries listed below.


Ingredient matches for Wick-Inhalierstift



Camphor

Camphor is reported as an ingredient of Wick-Inhalierstift in the following countries:


  • Germany

Levomenthol

Levomenthol is reported as an ingredient of Wick-Inhalierstift in the following countries:


  • Austria

  • Germany

International Drug Name Search


Sulfatrim Pediatric


Sulfatrim Pediatric is a brand name of sulfamethoxazole/trimethoprim, approved by the FDA in the following formulation(s):


SULFATRIM PEDIATRIC (sulfamethoxazole; trimethoprim - suspension; oral)



  • Manufacturer: ACTAVIS MID ATLANTIC

    Approval date: January 7, 1983

    Strength(s): 200MG/5ML;40MG/5ML [AB]

Has a generic version of Sulfatrim Pediatric been approved?


Yes. The following products are equivalent to Sulfatrim Pediatric:


SULFAMETHOXAZOLE AND TRIMETHOPRIM (sulfamethoxazole; trimethoprim suspension; oral)



  • Manufacturer: AUROBINDO PHARMA

    Approval date: June 8, 2010

    Strength(s): 200MG/5ML;40MG/5ML [AB]


  • Manufacturer: VINTAGE

    Approval date: January 24, 2007

    Strength(s): 200MG/5ML;40MG/5ML [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sulfatrim Pediatric. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Sulfatrim Pediatric.

See also...

  • Sulfatrim Pediatric Consumer Information (Cerner Multum)
  • Sulfatrim Pediatric Advanced Consumer Information (Micromedex)
  • Sulfamethoxazole/Trimethoprim Consumer Information (Wolters Kluwer)
  • Sulfamethoxazole/Trimethoprim Suspension Consumer Information (Wolters Kluwer)
  • Sulfamethoxazole/Trimethoprim Tablets Consumer Information (Wolters Kluwer)
  • Sulfamethoxazole and trimethoprim Consumer Information (Cerner Multum)
  • Apo-Sulfatrim Advanced Consumer Information (Micromedex)
  • Novo-Trimel Advanced Consumer Information (Micromedex)
  • Nu-Cotrimox Advanced Consumer Information (Micromedex)
  • Septa Pediatric Advanced Consumer Information (Micromedex)
  • Sulfamethoxazole/trimethoprim Advanced Consumer Information (Micromedex)
  • Sulfamethoxazole/trimethoprim Intravenous Advanced Consumer Information (Micromedex)
  • Trimethoprim and sulfamethoxazole Advanced Consumer Information (Micromedex)
  • Trimethoprim and sulfamethoxazole Intravenous Advanced Consumer Information (Micromedex)

Urusotoran




Urusotoran may be available in the countries listed below.


Ingredient matches for Urusotoran



Trichlormethiazide

Trichlormethiazide is reported as an ingredient of Urusotoran in the following countries:


  • Japan

International Drug Name Search


Dopram


Dopram is a brand name of doxapram, approved by the FDA in the following formulation(s):


DOPRAM (doxapram hydrochloride - injectable; injection)



  • Manufacturer: BAXTER HLTHCARE

    Approved Prior to Jan 1, 1982

    Strength(s): 20MG/ML [RLD][AP]

Has a generic version of Dopram been approved?


Yes. The following products are equivalent to Dopram:


doxapram hydrochloride injectable; injection



  • Manufacturer: BEDFORD

    Approval date: January 10, 2003

    Strength(s): 20MG/ML [AP]


  • Manufacturer: WATSON LABS

    Approval date: January 30, 1992

    Strength(s): 20MG/ML [AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Dopram. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Dopram.

See also...

  • Dopram Consumer Information (Wolters Kluwer)
  • Dopram AHFS DI Monographs (ASHP)
  • Doxapram Consumer Information (Wolters Kluwer)
  • Doxapram Hydrochloride AHFS DI Monographs (ASHP)